Table of Content



1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Skin Cancer Diagnostics Market – By Type
1.3.2 Global Skin Cancer Diagnostics Market – By Screening Type
1.3.3 Global Skin Cancer Diagnostics Market – By Geography

2. Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Skin Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America– PEST Analysis
4.2.2 Europe– PEST Analysis
4.3 Expert Opinion

5. Skin Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Skin Cancer
5.1.2 Launch of New Products
5.2 Market Restraints
5.2.1 Barriers to Early Skin Cancer Diagnostics in Low and Middle-Income Countries
5.3 Market Opportunities
5.3.1 Government Support for Early Skin Cancer Diagnosis
5.4 Future Trends
5.4.1 Skin Cancer Diagnostics Through AI
5.5 Impact Analysis

6. Skin Cancer Diagnostics Market – Global Analysis
6.1 Global Skin Cancer Diagnostics Market Revenue Forecast and Analysis
6.2 Global Skin Cancer Diagnostics Market Revenue Forecast and Analysis
6.3 Market Positioning of Key Players

7. Skin Cancer Diagnostics Market Analysis – By Type
7.1 Overview
7.2 Skin Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
7.3 Melanoma
7.3.1 Overview
7.3.2 Melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Non-melanoma
7.4.1 Overview
7.4.2 Non-melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8. Skin Cancer Diagnostics Market – By Screening Type
8.1 Overview
8.2 Skin Cancer Diagnostics Market, by Screening Type, 2021 and 2028 (%)
8.3 Blood Tests
8.3.1 Overview
8.3.2 Blood Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Dermatoscopy
8.4.1 Overview
8.4.2 Dermatoscopy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Imaging Tests
8.5.1 Overview
8.5.2 Imaging Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Lymph Node Biopsy
8.6.1 Overview
8.6.2 Lymph Node Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Skin Biopsy
8.7.1 Overview
8.7.2 Skin Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Skin Cancer Diagnostics Market – Regional Analysis
9.1 North America: Skin Cancer Diagnostics Market
9.1.1 Overview
9.1.2 North America: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ?Million)
9.1.3 North America: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ?Million)
9.1.4 North America: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ Million)
9.1.5 North America: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ?Million)
9.1.5.1.1 US: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ?Million)
9.1.5.1.2 US: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ?Million)
9.1.5.1.3 US: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ?Million)
9.1.5.2 Canada: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ?Million)
9.1.5.2.1 Canada: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ?Million)
9.1.5.2.2 Canada: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ?Million)
9.1.5.2.3 Canada: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ?Million)
9.1.5.3 Mexico: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ?Million)
9.1.5.3.1 Mexico: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ?Million)
9.1.5.3.2 Mexico: Skin Cancer Diagnostics Market, by Type, 2019–2028 (US$ ?Million)
9.1.5.3.3 Mexico: Skin Cancer Diagnostics Market, by Screening Type, 2019–2028 (US$ ?Million)
9.2 Europe: Skin Cancer Diagnostics Market
9.2.1 Overview
9.2.2 Europe: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.4 Europe: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.2.5 Europe: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.2.5.1 Germany: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 Overview
9.2.5.1.2 Germany: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.3 Germany: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.5.1.4 Germany: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.2.5.2 United Kingdom: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.1 Overview
9.2.5.2.2 United Kingdom: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.3 United Kingdom: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.5.2.4 United Kingdom: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.2.5.3 France: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 Overview
9.2.5.3.2 France: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.3 France: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.5.3.4 France: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.2.5.4 Italy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Overview
9.2.5.4.2 Italy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.3 Italy: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.5.4.4 Italy: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.2.5.5 Spain: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Overview
9.2.5.5.2 Spain: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.3 Spain: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.5.5.4 Spain: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.2.5.6 Rest of Europe: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Overview
9.2.5.6.2 Rest of Europe: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.2.5.6.4 Rest of Europe: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
10. Impact of COVID-19 Pandemic on Global Skin Cancer Diagnostics Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
11. Skin Cancer Diagnostic Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Skin Cancer Diagnostic Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 SkylineDx BV
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 SWOT Analysis
12.1.5 Key Developments
12.2 AMLo Biosciences Limited
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 SWOT Analysis
12.2.5 Key Developments
12.3 NeraCare GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 SWOT Analysis
12.3.5 Key Developments
12.4 DermLite LLC
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 bioMerieux SA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Veriskin Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Castle Biosciences, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DermTech Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 HOFFMANN-LA ROCHE LTD.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.10 Michelson Diagnostics Ltd.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms



List of Figures

LIST OF FIGURES
Figure 1. Skin Cancer Diagnostics Market Segmentation
Figure 2. Skin Cancer Diagnostics Market, By Region
Figure 3. Global Skin Cancer Diagnostics Market Overview
Figure 4. Non-Melanoma Segment Held Largest Share of Type Segment in Skin Cancer Diagnostics Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Skin Cancer Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Skin Cancer Diagnostics Market- Leading Country Markets (US$ Million)
Figure 8. Global Skin Cancer Diagnostics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Skin Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 12. Global Skin Cancer Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 13. Global Skin Cancer Diagnostics Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 14. Market Positioning of Key Players in Global Skin Cancer Diagnostics Market
Figure 15. Skin Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)
Figure 16. Melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Non-melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Skin Cancer Diagnostics Market, by Screening Type, 2021 and 2028 (%)
Figure 19. Blood Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Dermatoscopy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Imaging Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Lymph Node Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Skin Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America: Skin Cancer Diagnostics Market, by Key Country – Revenue (2021) (US$ ?Million)
Figure 25. North America: Skin Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ ?Million)
Figure 26. North America: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 27. US: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ?Million)
Figure 28. Canada: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ?Million)
Figure 29. Mexico: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ ?Million)
Figure 30. Europe: Skin Cancer Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 31. Europe Skin Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. Europe: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 33. Germany: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. United Kingdom: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. France: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Italy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Spain: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Rest of Europe: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Impact Of COVID-19 Pandemic in North American Country Markets
Figure 40. Impact of COVID-19 Pandemic in European Country Markets
Figure 41. Growth Strategies in the Skin Cancer Diagnostic Market (%) 1

List of Tables

LIST OF TABLES
Table 1. North America: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ?Million)
Table 2. North America: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. US: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ?Million)
Table 4. US: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ?Million)
Table 5. Canada: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ?Million)
Table 6. Canada: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ?Million)
Table 7. Mexico: Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ?Million)
Table 8. Mexico: Skin Cancer Diagnostics Market, by Screening Type – Revenue and Forecast to 2028 (US$ ?Million)
Table 9. Europe Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. Europe Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 11. Germany Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Germany Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 13. United Kingdom Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. United Kingdom Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 15. France Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 16. France Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 23. Organic Developments in the Skin Cancer Diagnostic Market
Table 24. Inorganic Developments in the Skin Cancer Diagnostics Market
Table 25. Glossary of Terms, Skin Cancer Diagnostics Market
Table 26. Acronym